ClinicalTrials.govpublic full text
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
solid tumors, advanced cancer, hormonal therapies, estrogen receptor, progesterone receptor, hormone blockade, hormone-positive tumors, metastatic cancer, avastin, anti-vegf monoclonal antibody, rhumab-vegf, afinitor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 879684
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.